Fusidic acid cream in the treatment of impetigo in general practice: double blind randomised placebo controlled trial
- 26 January 2002
- Vol. 324 (7331), 203
- https://doi.org/10.1136/bmj.324.7331.203
Abstract
Objective: To test the hypothesis that fusidic acid would not increase the treatment effect of disinfecting with povidone-iodine alone in children with impetigo. Design: Randomised placebo controlled trial. Setting: General practices in Greater Rotterdam. Participants: 184 children aged 0-12 years with impetigo. Main outcome measures: Clinical cure and bacterial cure after one week. Results: After one week of treatment 55% of the patients in the fusidic acid group were clinically cured compared with 13% in the placebo group (odds ratio 12.6, 95% confidence interval 5.0 to 31.5, number needed to treat 2.3). After two weeks and four weeks the differences in cure rates between the two groups had become smaller. More children in the placebo group were non-compliant (12 v 5) and received extra antibiotic treatment (11 v 3), and more children in the placebo group reported adverse effects (19 v 7). Staphylococcus aureus was found in 96% of the positive cultures; no strains were resistant to fusidic acid. Conclusions: Fusidic acid is much more effective than placebo (when both are given in combination with povidone-iodine shampoo) in the treatment of impetigo. Because of the low rate of cure and high rate of adverse events in the placebo group, the value of povidone-iodine in impetigo can be questioned. What is already known on this topic Impetigo is the most common skin infection in children Fusidic acid, which is advocated as topical treatment in several countries, has never been investigated in a placebo controlled study What this study adds In combination with povidone-iodine, treatment with fusidic acid is much more effective than placebo None of the strains of Staphylococcus aureus isolated at baseline showed resistance to fusidic acid The value of treatment with povidone-iodine alone can be questionedKeywords
This publication has 14 references indexed in Scilit:
- Resistance to antibiotics used in dermatological practiceBritish Journal of Dermatology, 1998
- Resistance of staphylococci in The Netherlands: surveillance by an electronic network during 1989-1995Journal of Antimicrobial Chemotherapy, 1998
- COMPARISON OF ORAL CEPHALEXIN, TOPICAL MUPIROCIN AND TOPICAL BACITRACIN FOR TREATMENT OF IMPETIGOThe Pediatric Infectious Disease Journal, 1997
- Double-blind study comparing erythromycin and mupirocin for treatment of impetigo in children: implications of a high prevalence of erythromycin-resistant Staphylococcus aureus strainsAntimicrobial Agents and Chemotherapy, 1992
- Comparison of mupirocin and erythromycin in the treatment of impetigoThe Journal of Pediatrics, 1990
- Topical 2% mupirocin versus 2% fusidic acid ointment in the treatment of primary and secondary skin infectionsJournal of the American Academy of Dermatology, 1989
- Prescribing Antibiotics for ImpetigoDrugs, 1988
- A comparison of sodium fusidate ointment and mupirocin ointment in superficial skin sepsisCurrent Medical Research and Opinion, 1988
- Treatment of impetigoThe Pediatric Infectious Disease Journal, 1985
- FUCIDIN: A New Orally Active AntibioticThe Lancet, 1962